Effects Of Emotional Freedom Technique and Hypermesis Gravidarum

NCT06442813 | Not Yet Recruiting

• 2 other identifiers: E-54022451-050.05.04-91178MMeseduzu
• Study Type: interventional
• Target: 74
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this clinical study is to determine whether EFT (Emotional Freedom Techniques) is effective in alleviating nausea and vomiting in pregnant women with hyperemesis. Additionally, the study aims to gather information on the safety of EFT application. The primary questions it seeks to answer are: Does EFT reduce nausea and vomiting in pregnant women with hyperemesis? Is EFT applicable for use in pregnant women with hyperemesis? Researchers will compare the effectiveness of EFT to traditional nursing education on non-pharmacological interventions for preventing nausea and vomiting in pregnant women with hyperemesis. Participants: Pre-EFT application survey scale questions will be asked to the pregnant women with hyperemesis. EFT will be applied once by the researcher to the pregnant women with hyperemesis. For control, the same survey scale questions will be asked to the same pregnant women two days after the EFT application for post-test purposes. For control, the same survey scale questions will be asked to the same pregnant women seven days after the EFT application for post-test purposes. The same procedures will be applied in the same manner to the control group that will receive education.

Conditions

Hyperemesis Gravidarum; Pregnancy

Keywords

hyperemesis gravidarum; quality life; pregnancy; Emotional Freedom Techniques

Outcome Measures

Primary Outcomes (1)

• Pregnancy-Unique Quantification of Emesis and Nausea (PUQE-24)

  The degree of reduction in the severity of nausea and vomiting. The PUQE-24 (Pregnancy-Unique Quantification of Emesis and Nausea) scale is used, where each question is scored between 1 and 5. The total score is the sum of these three questions. Minimum Score: 3 (each question scoring 1) Maximum Score: 15 (each question scoring 5) These scores are used to rate the severity of nausea and vomiting in pregnancy. Lower scores indicate milder symptoms, while higher scores indicate more severe symptoms.

  3 months

Secondary Outcomes (1)

• WHOQOL-BREF (World Health Organization Quality of Life - BREF)

  3 months

Study Arms (2)

EXPERİMENTAL GROUP

EXPERIMENTAL

First Stage: Determining the groups by randomization method and filling out the data collection forms for the groups (pre-test). Second Stage: Training pregnant women in the control group on the management of standard hyperemesis gravidarum (training content will be prepared and opinions will be obtained from 3 experts in the field). For the intervention group, pregnant women were given a session with EFT (Average: 40-60 minutes) and a program was created for the pregnant woman to do affirmations in between depending on her condition (Positiveness with EFT strokes 3 times a day). Third Stage: After 15 days, it is planned to conduct post-tests for both groups and complete the study. In the final stage, pregnant women\'s questions will be answered, counseling will continue where deemed necessary, and prepared training booklets will be given to pregnant women

Behavioral: EFT GROUP

CONTROL GROUP

NO INTERVENTION

Pregnant women diagnosed with hyperemesis gravidarum (HG) who meet the inclusion criteria for the study will constitute the control group. Providing training to the control group only for HG management (training content will be prepared and opinions will be obtained from 3 experts in the field).

Interventions

EFT GROUP BEHAVIORAL

One times one pregnancy

Also known as: emotıonal free technıcal

EXPERİMENTAL GROUP

Eligibility Criteria

• Age: 20 Years - 40 Years
• Gender Eligibility Details: Pregnancy
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Pregnant women between 6-14 weeks of pregnancy
• Pregnant women between the ages of 20-40
• Pregnant women with complaints of nausea and vomiting
• Pregnant women who report their discomfort as 5 or above on the vas scale
• Pregnant women who have not been diagnosed with risky pregnancy
• Pregnant women who do not have any psychological disorders
• Pregnant women who voluntarily agreed to participate in the research

You may not qualify if:

• Coordination and language problems in the pregnant woman
• Wants to leave the study at any time
• Not wanting to participate in the study

Sponsors & Collaborators

• Bezmialem Vakif University: lead

Study Sites (1)

Bezmialem Vakif Universty

Istanbul, Fatih, 34093, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hyperemesis Gravidarum

Condition Hierarchy (Ancestors)

Morning Sickness; Pregnancy Complications; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Vomiting; Signs and Symptoms, Digestive; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Merve MESEDUZU, LECTURER

CONTACT

800-555-5555; mervemeseduzu@gmail.com

LECTURER

CONTACT

800-555-5555

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: LECTURER

Model Details: EXPERIMENTAL GROUP First Stage: Determining the groups by randomization method and filling out the data collection forms for the groups (pre-test). Second Stage: Training pregnant women in the control group on the management of standard hyperemesis gravidarum (training content will be prepared and opinions will be obtained from 3 experts in the field). For the intervention group, pregnant women were given a session with EFT (Average: 40-60 minutes) and a program was created for the pregnant woman to do affirmations in between depending on her condition (Positiveness with EFT strokes 3 times a day). Third Stage: After 15 days, it is planned to conduct post-tests for both groups and

Study Record Dates

• First Submitted: January 12, 2024
• First Posted: June 4, 2024
• Study Start: June 10, 2024
• Primary Completion: August 20, 2024
• Study Completion: August 30, 2024
• Last Updated: June 4, 2024

Record last verified: 2024-05

Locations

TU (1)